Additional guidance was provided for managing patients presenting with GI symptoms and for patients who did not hold their GLP-1 RA as advised
This allows us to track your bodys response, assess efficacy, and identify any potential adverse effects early
10 children (30.3%) experienced mild side effects
Global GLP-1 Receptor Agonist Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Semaglutide, Dulaglutide, Liraglutide, Exenatide), By Type (Victoza, Ozempic, Saxenda, Trulicity, Bydureon), By Application (Type 2 Diabetes, Obesity, and Others), By Route of Administration (Parenteral and Oral), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 2032 Industry: Healthcare Global GLP-1 Receptor Agonist Market Insights Forecasts to 2032 The Global GLP-1 Receptor Agonist Market Size was valued at USD 13.4 Billion in 2022
Schizophrenia (SCZ), another prevalent mental disorder, has an incidence rate of ~0.5% in China [184]